BI
Bioextrax AB (publ)
BIOEX.ST · STO
2.38 kr +0.42% (+0.01 kr)
1M -6.30%
Market Cap 113.3M kr
P/E Ratio -
Div. Yield -
ROE 111.12%
Piotroski F-Score Weak
0/9Valuation
17 /100
Expensive P/S 149.66x
P/B 5.34x
P/E N/A
Growth
78 /100
Growing Rev. growth 24.21%
Book val. growth 12.59%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 2,426.42%
FCF margin 3,460.77%
Net margin 2,338.84%
Quality
0 /100
Poor ROIC 86.58%
Asset turnover 0.03x
ROE 111.12%
Debt
64 /100
Moderate Debt/Equity 0.00x
Int. coverage -18,368.00x
Current ratio 1.58x
Stability
39 /100
Moderate Beta 1.49x
Profitable years 0
Rev. volatility 258.15%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOEX.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Edvard Hall
Employees
14
Headquarters
Lund
Evenimente viitoare
20 NOV.
Earnings
Upcoming earnings report